Duke Vaccine and Trials Unit CRS

Durham, North Carolina 27703

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus (RSV)

Studies at this site

• Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age — Stopped early